GSK Receives US FDA File Acceptance for Jemperli
JP Morgan European Growth and Income plc Final Results for the Year End 31st March 2023
British American Tobacco plc 2023 H1 Pre-Close Trading Update
B.P.Marsh and Partners plc Use of Proceeds of Sale (£51.5m) and Strategy Update
Anpario plc Proposed Tender offer of up to 4 Million Shares
AVI Global Trust plc- Unaudited Results for Half-Year Ended 31st March 2023
Lynparza Approved in US for BRCAm Prostate Cancer
